NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Neuraxis, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$7.85+0.15 (+1.95%)
Close on Oct 19, 2026
- Market cap
- $95.14M
- P/E (TTM)
- –
- Dividend yield
- –
Neuraxis, INC revenue by segment
By business segment
By product or service
By region
| Revenue | Q4 23 | Q3 23 | Q2 23 | Q4 22 | Q3 22 | Q2 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| OH | $129.13K | $129.20K | – | $125.59K | $122.40K | $122.60K | 24.3% | +2.8% |
| Canada | $87.84K | $138.08K | $162.70K | $138.84K | $76.90K | $115.93K | 16.5% | -36.7% |
| WI | $69.26K | $24.70K | $87.60K | $109.90K | $126.73K | $166.64K | 13.0% | -37.0% |
| FL | $51.43K | $37.81K | $52.58K | $52.41K | $71.70K | $97.82K | 9.7% | -1.9% |
| All other States [Member] | $43.56K | $126.17K | $245.02K | $154.77K | $158.94K | $146.14K | 8.2% | -71.9% |
| Macao SAR China | – | $600 | $45.02K | $31.58K | $62.14K | $33.46K | – | – |
| Israel | – | $21.51K | $53.11K | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Neuraxis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.